Mach, F, Baigent, C, Catapano, AL, Koskinas, KC, Casula, M, Badimon, L, Chapman, MJ, De Backer, GG, Delgado, V, Ference, BA, Graham, IM, Halliday, A, Landmesser, U, Mihaylova, B, Pedersen, TR, Riccardi, G, Richter, DJ, Sabatine, MS, Taskinen, MR, Tokgozoglu, L, Wiklund, O, Nibouche, D, Zelveian, PH, Siostrzonek, P, Najafov, R, van de Borne, P, Pojskic, B, Postadzhiyan, A, Kypris, L, Špinar, J, Larsen, ML, Eldin, HS, Viigimaa, M, Strandberg, TE, Ferrieres, J, Agladze, R, Laufs, U, Rallidis, L, Bajnok, L, Gudjonsson, T, Maher, V, Henkin, Y, Gulizia, MM, Mussagaliyeva, A, Bajraktari, G, Kerimkulova, A, Latkovskis, G, Hamoui, O
, Visseren, F, Grobbee, D 2020, '
Erratum to “2019 ESC/EAS guidelines for the management of dyslipidemias: Lipid modification to reduce cardiovascular risk” [Atherosclerosis 290 (2019) 140–205]',
Atherosclerosis, vol. 292, pp. 160-162.
https://doi.org/10.1016/j.atherosclerosis.2019.11.020